The Food and Drug Administration (FDA) has designated Conexxence ® (denosumab-bnht) and Bomyntra ® (denosumab-bnht) as interchangeable biosimilars to the reference products Prolia ® (denosumab) and ...
If finalized, the rule would override state laws, including those that ban reporting of medical debt on consumer credit reports ...
Rates for plans sold through federal Obamacare marketplaces will rise, on average, by 30% next year, according to a new analysis from the health research group KFF. States that run their own ...
HealthDay News — The stillbirth rate in the US from 2016 through 2022 appears to be higher than the rate reported in 2021 by the US Centers for Disease Control and Prevention, according to a research ...
HealthDay News — Exposure to the volatile organic compound tetrachloroethylene (PCE) is associated with a higher risk for significant liver fibrosis, according to a study published online October 16 ...
Specific recommendations made for adult, pediatric, neonatal life support; resuscitation education; systems of care.
HealthDay News — Canada may lose its measles elimination status amid a yearlong outbreak that has infected more than 5000 people and killed two infants, health officials said this week.
Findings showed Staloral Birch, compared with placebo, demonstrated a 41% improvement in the ARC total combined score during the second pollen season. Topline data were announced from a phase 3b trial ...
Greater waist circumference reduction at week 20 linked to lower subsequent MACE risk for those receiving semaglutide.
Patient and graft survival similar for patients receiving DCD-V from MAiD donation versus conventional DCD-III grafts.
The Food and Drug Administration (FDA) has designated Stoboclo ® (denosumab-bmwo) and Osenvelt ® (denosumab-bmwo) as interchangeable biosimilars to the reference products Prolia ® (denosumab) and ...
The U.S. Food and Drug Administration says no link between Tylenol use during pregnancy and autism has been proven.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results